ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.351,41
1,04%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,06931
-0,15%
Bitcoin
61.450,72
-0,58%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AC Immune SA (ACIU)

  7. AC Immune SA (ACIU) News

ACIU

AC Immune (ACIU)

AC Immune SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACIU
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
16/05/202420h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
13/05/202412h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
13/05/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
09/02/202422h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACIUAC Immune SA
22/01/202413h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
03/01/202422h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
03/01/202414h10GlobeNewswire Inc.AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseasesNASDAQ:ACIUAC Immune SA
28/12/202322h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
19/12/202314h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
15/12/202323h27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACIUAC Immune SA
15/12/202322h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
15/12/202313h27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
11/12/202322h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
06/12/202322h37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
01/12/202313h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
03/11/202312h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
22/08/202322h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
21/08/202322h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
17/08/202322h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
09/08/202322h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
08/08/202322h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
04/08/202313h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
26/07/202313h17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
24/07/202322h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
21/07/202322h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
18/07/202322h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
13/07/202322h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
12/07/202322h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
10/07/202322h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
 Showing the most relevant articles for your search:NASDAQ:ACIU

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
CCOM
US500
US 500
TG
D7G
Nel ASA
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
AMEX
SPY
SPDR S&P 500
CCOM
US100
US Tech 100
FX
EURJPY
Euro vs Yen
DBI
SDXP
SDAX
FX
EURUSD
Euro vs US Dollar
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten